Molecular design based on 3D pharmacophores. Applications to 5-HT 7 receptors

Journal of Chemical Information and Computer Sciences

Volumn 44, Issue 3, 2004, Pages 1148-1152

  Lepailleur, Alban ^a   Bureau, Ronan ^a   Lemaître, Stéphane ^a   Dauphin, François ^a   Lancelot, Jean Charles ^a   Contesse, Vincent ^b   Lenglet, Sébastien ^b   Delarae, Catherine ^b   Vaudry, Hubert ^b   Rault, Sylvain ^a  

^a CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

^b UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3D PHARMACOPHORES; CATIONIC NEUROTRANSMITTERS; PATHOGENESIS; SCHIZOPHRENIA;

DATA REDUCTION; DATABASE SYSTEMS; DISEASES; HYDROPHOBICITY; MOLECULAR DYNAMICS; OPTIMIZATION; SULFUR; SYNTHESIS (CHEMICAL);

PHARMACODYNAMICS;

SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; PROTEIN CONFORMATION;

MODELS, MOLECULAR; PROTEIN CONFORMATION; RECEPTORS, SEROTONIN;

EID: 2942720958     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci030036l     Document Type: Article

References (31)

1. Korolkovas, A. Essentials of Molecular Pharmacology, Background for drug design; Interscience: New York, 1970.
2. Gund, P. Three-dimensional pharmacophore pattern searching. In Progress in Molecular and Subcellular Biology; Hahn, F. E., Ed.; Springer-Verlag: Berlin, 1977; Vol. 5, p 117.
3. Gund, P. Pharmacophoric pattern searching and receptor mapping. Annu. Rep. Med. Chem. 1979, 14, 299-308.
4. Humblet, C.; Marshall, G. R. Pharmacophore identification of receptor mapping. Annu. Rep. Med. Chem. 1980, 15, 267-276.
5. Catalyst version 4.5 software, Accelrys Inc., San Diego, CA, 2001.
6. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Karting, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol. Rev. 1994, 46, 157-203.
7. Zifa, E.; Fillion, G. 5-Hydroxytryptamine Receptors. Pharmacol. Rev. 1992, 44, 401-458.
8. Peroutka, S. J. 5-Hydroxytryptamine receptor subtypes. In Serotonin receptors and their ligands; Olivier, B., Van Wijngaarden, I., Soudijn, W., Eds.; Elsevier (pharmacochemistry library): Amsterdam, 1997; Vol. 27, pp 3-13.
9. 3 Receptors. J. Chem. Inf. Comput. Sci. 1999, 39, 362-369.
10. 4 Receptor. J. Chem. Inf. Comput. Sci. 2002, 42, 962-967.
11. Bureau, R.; Daveu, C.; Lancelot, J. C.; Rault, S. Molecular Design Based on 3D-Pharmacophore. Application to 5-HT Subtypes Receptors. J. Chem. Inf. Comput. Sci. 2002, 42, 429-436.
12. Pouzet, B. SB-258741: a 5-HT7 receptor antagonist of potential clinical interest. CNS Drug Rev. 2002, 8, 90-100.
13. Wood, M. D.; Thomas, D. R.; Watson, J. M. Therapeutic potential of serotonin antagonists in depressive disorders. Expert Opin. Invest. Drugs 2002, 11, 457-467.
14. Pouzet, B.; Didriksen, M. Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia. Pharmacol, Biochem., Behav. 2002, 71, 655-665.
15. Lopez-Rodriguez, M. L.; Porras, E.; Benhamu, B.; Ramos, J. A.; Morcillo, M. J.; Lavandera, J. L. First Pharmacophoric Hypothesis for 5-HT7 Antagonism. Bioorg. Med. Chem. Lett. 2000, 10, 1097-1100.
16. 7 Receptor Antagonist. J. Med. Chem. 1998, 41, 655-657.
17. 7 Antagonist: (R)-3-(2-(2-(4-methylpiperidin-l-yl)- ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J. Med. Chem. 2000, 43, 342-345.
18. 7 Receptor Antagonists. J. Med. Chem. 2001, 44, 1337-1340.
19. 7 Receptor. J. Med. Chem. 1999, 42, 533-535.
20. 7 Receptor. Bioorg. Med. Chem. Lett. 2002, 12, 2549-2552.
21. Sybyl 6.9, Tripos Inc., St. Louis, MO, 2003.
22. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; Sates, D. J.; Swaninathan, S.; Karplus, M. CHAMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 1983, 4, 187-217.
23. Smellie, A.; Teig, S. L.; Towbin, P. Poling: Promoting Conformational Variation. J. Comput. Chem. 1995, 16, 171-187.
24. Rault, S.; Lancelot, J. C.; Prunier, H.; Robba, M.; Renard, P.; Delagrange, P.; Pfeiffer, B.; Caignard, D. H.; Guardiola-Lemaître, B.; Hamon, M. Novel Selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines. J. Med. Chem. 1996, 39, 2068-2080.
25. Shen, Y.; Monsma, F. J.; Metcalf, M. A.; Jose, P. A.; Hamblin, M. W.; Sibley, D. R. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 1993, 268, 18200-18204.
26. Hansch. C.; Leo, A. Exploring QSAR; American Chemical Society: Washington, DC, 1995.
27. Rekker, R. F.; Mannhold, R. Calculation of Drug Lipophilicity; VCH: New York, 1992.
28. Hansch, C.; Leo, A. Calculation of Octanol-Water Partition Coefficients by Fragments. Exploring QSAR; American Chemical Society: Washington, DC, 1995; p 125.
29. Wang, R.; Fu, Y.; Lai, L. a New Atom-Additive Method for Calculating Partition Coefficients. J. Chem. Inf. Comput. Sci. 1997, 37, 615-621.
30. 7 Receptors in the Rat Adrenal Gland. Mol. Pharmacol. 1999, 56, 552-561.
31. 7 Receptor in Rat Glomerulosa Cells is Associated with an Increase in Adenylyl Cyclase Activity and Calcium Influx through T-Type Calcium Channels. Endocrinology 2002, 143, 1748-1760.